Brief: Kali Says Co Receives Proposal To Certify Its CBD Extract As OTC Drug Under FDA Requirements
04/09/2019 14:14
Sept 4 (Reuters) - Kali Inc KALY.PK :
* KALI INC - CO RECEIVES PROPOSAL TO CERTIFY ITS CBD EXTRACT
AS
OTC DRUG UNDER FDA REQUIREMENTS
Source text for Eikon: ID:nGNX6qVN8
Further company coverage: KALY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kali
See all newsBrief: KALY-Kali-Extracts RespRx Could Offer Treatment For Coronavirus Symptoms
Brief: Pura Explores Acquisition Of Kaly CBD Confection Assets
Brief: Kaly Confirms Consolidation Plans To Focus On $50 Bln Cannabis Biopharmaceutical Market Opportunity
Brief: Kali-Extracts Plans To Certify CBD Extract As OTC Drug Under FDA Requirements
Brief: Kali Says Co Receives Proposal To Certify Its CBD Extract As OTC Drug Under FDA Requirements